Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
OncoVista Innovative Therapies, Inc. (OTCBB:OVIT) reported that it has initiated an additional safety study of OVI-117 in a 2nd animal species. “OncoVista is moving ahead...
OncoVista Innovative Therapies, Inc., (OTCBB:OVIT) reported in a letter to shareholders that it is moving forward on its business plan to develop targeted, safer and more...
OncoVista Innovative Therapies, Inc. (OTCBB: OVIT), a high-growth global biopharmaceutical company commercializing diagnostic tests for metastatic tumors, as well as developing...
AdnaGen AG, a subsidiary of OncoVista Innovative Therapies, Inc. (OTCBB: OVIT), a high-growth global biotech company developing proprietary, leading-edge early detection and...
OncoVista Innovative Therapies, Inc. (OTCBB: OVIT), a high-growth global biotech company developing proprietary, leading-edge early detection and drug technologies to enable...
OncoVista Innovative Therapies, Inc. (OTCBB: OVIT), a high-growth global biotech company developing proprietary, leading-edge early detection and drug technologies to enable...
OncoVista Innovative Therapies, Inc. (OTCBB:OVIT) announced today that its wholly owned subsidiary, AdnaGen AG, the manufacturer of CE-certified circulating tumor cell (CTC...
OncoVista Innovative Therapies, Inc. (OTCBB: OVIT) announced today that its application for reinstatement on the Over-The-Counter Bulletin Board has been accepted...
OncoVista Innovative Therapies, Inc. (Pink Sheets:OVIT), reported that the AdnaTest BreastCancer Select & Detect kit, manufactured by AdnaGen AG (Langenhagen, Germany), is now...
OncoVista Innovative Therapies, Inc. (Pink Sheets: OVIT) reported continued strong growth in revenue, in the third quarter of 2009. For the nine months ended, revenues increased...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | -0.0001 | -50 | 0.0002 | 0.0002 | 0.0001 | 6868 | 0.00012719 | CS |
| 12 | 9.9E-5 | 9900 | 1.0E-6 | 0.0002 | 1.0E-6 | 4578 | 0.00012719 | CS |
| 26 | 0 | 0 | 0.0001 | 0.0002 | 1.0E-6 | 4767 | 4.645E-5 | CS |
| 52 | 9.9E-5 | 9900 | 1.0E-6 | 0.0002 | 1.0E-6 | 24193 | 9.222E-5 | CS |
| 156 | 9.9E-5 | 9900 | 1.0E-6 | 0.0002 | 1.0E-6 | 22796 | 0.00013174 | CS |
| 260 | -0.01696 | -99.4138335287 | 0.01706 | 0.137 | 1.0E-6 | 36900 | 0.0370106 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
